Missouri Trust & Investment Company’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,000
Closed -$102K 416
2025
Q4
$102K Hold
1,000
0.03% 172
2025
Q3
$54.7K Hold
1,000
0.02% 224
2025
Q2
$53.1K Hold
1,000
0.02% 212
2025
Q1
$43.3K Sell
1,000
-300
-23% -$15.2K 0.02% 219
2024
Q4
$73K Hold
1,300
0.03% 179
2024
Q3
$88.6K Hold
1,300
0.03% 166
2024
Q2
$54.9K Hold
1,300
0.02% 198
2024
Q1
$89.8K Hold
1,300
0.03% 160
2023
Q4
$96.2K Hold
1,300
0.04% 149
2023
Q3
$88.7K Hold
1,300
0.04% 146
2023
Q2
$122K Buy
+1,300
New +$101K 0.07% 139

Other funds holding EXAS

Missouri Trust & Investment Company's EXAS Position: Q1 2026 in Review

Missouri Trust & Investment Company sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,000 shares — an estimated $102K sold.

Missouri Trust & Investment Company first reported a position in EXAS in Q2 2023 and held it in 11 quarters. The position peaked at $122K in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Missouri Trust & Investment Company reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Missouri Trust & Investment Company sold 1,000 Exact Sciences shares in Q1 2026, an estimated $102K.
  • Missouri Trust & Investment Company first reported a position in Exact Sciences in Q2 2023 and held it in 11 quarters.
  • Missouri Trust & Investment Company's Exact Sciences position peaked at $122K in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q1 2026, filed 14 May 2026.